Spots Global Cancer Trial Database for Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer.
Official Title: Rivaroxaban or Placebo for Extended Antithrombotic Prophylaxis After Laparoscopic Surgery for Colorectal Cancer: a Randomized, Double Blind, Placebo-controlled Study.
Study ID: NCT03055026
Conditions
Study Description
Brief Summary: Rivaroxaban or placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer: a randomized, double blind, placebo-controlled study.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Ospedale Santa Maria delle Grazie, Pozzuoli, Napoli, Italy
Ospedale di Cittadella, Cittadella, Padova, Italy
Ospedale San Matteo degli Infermi, Spoleto, Perugia, Italy
Ospedale E. Agnelli, Pinerolo, Torino, Italy
Ospedale San Giacomo Apostolo, Castelfranco Veneto, Treviso, Italy
Istituto Clinico Humanitas Mater Domini, Castellanza, Varese, Italy
Ospedale San Donato, Arezzo, , Italy
AOU Careggi, Firenze, , Italy
Nuovo Ospedale "San Giovanni Battista", Foligno, , Italy
AOU Federico II, Napoli, , Italy
IRCCS Fondazione Pascale, Napoli, , Italy
Policlinico di Padova, Padova, , Italy
Ospedale Santa Maria della Misericordia, Perugia, , Italy
Ospedale San Salvatore, Pesaro, , Italy
Ospedale di Piacenza, Piacenza, , Italy
Policlinico Gemelli, Roma, , Italy
Ospedale Santa Maria, Terni, , Italy
Contact Details
Name: Mauro Campanini
Affiliation: FADOI Foundation
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
